KIORA PHARMACEUTICALS, INC. Operating Expenses
KIORA PHARMACEUTICALS, INC. (KPRX) reported Operating Expenses of $2.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-06-30 was $2.21M, a 7.61% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2026-03-31 was $2.51M, a 7.72% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-12-31 was $7.31M, a 185.03% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2025-09-30 was $794.44K, a 77.95% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. operating expenses for fiscal 2025 was $12.83M, a 11.48% increase from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. operating expenses for fiscal 2024 was $11.51M, a 8.56% decline from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $12.59M, a 2.25% increase from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $12.31M, a 13.53% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.21M 10-Q · filed 2026-08-07 | $4.72M 10-Q · filed 2026-08-07 | $12.03M derived: sum of 3 quarters · filed 2026-08-07 | $12.83M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $2.51M 10-Q · filed 2026-05-08 | $9.82M derived: sum of 2 quarters · filed 2026-05-08 | $10.61M derived: sum of 3 quarters · filed 2026-05-08 | $13.01M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $8.10M derived: sum of 2 quarters · filed 2026-03-25 | $10.50M derived: sum of 3 quarters · filed 2026-08-07 | $12.83M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $794.44K 10-Q · filed 2025-11-07 | $3.19M derived: sum of 2 quarters · filed 2026-08-07 | $5.52M 10-Q · filed 2025-11-07 | $8.09M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-07 | $2.40M 10-Q · filed 2025-08-08 | $4.73M 10-Q · filed 2026-08-07 | $7.29M derived: sum of 3 quarters · filed 2026-08-07 | $10.89M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $2.33M 10-Q · filed 2026-05-08 | $4.90M derived: sum of 2 quarters · filed 2026-05-08 | $8.50M derived: sum of 3 quarters · filed 2026-05-08 | $11.06M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $6.17M derived: sum of 2 quarters · filed 2026-03-25 | $8.73M derived: sum of 3 quarters · filed 2026-03-25 | $11.51M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $3.60M 10-Q · filed 2025-11-07 | $6.17M derived: sum of 2 quarters · filed 2025-11-07 | $8.95M 10-Q · filed 2025-11-07 | $11.06M derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $2.56M 10-Q · filed 2025-08-08 | $5.34M 10-Q · filed 2025-08-08 | $7.46M derived: sum of 3 quarters · filed 2025-08-08 | $13.38M derived: sum of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | $2.78M 10-Q · filed 2025-05-09 | $4.90M derived: sum of 2 quarters · filed 2025-05-09 | $10.82M derived: sum of 3 quarters · filed 2025-05-09 | $13.45M derived: sum of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $8.04M derived: sum of 2 quarters · filed 2025-03-25 | $10.67M derived: sum of 3 quarters · filed 2025-03-25 | $12.59M 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $5.92M 10-Q · filed 2024-11-08 | $8.55M derived: sum of 2 quarters · filed 2024-11-08 | $10.47M 10-Q · filed 2024-11-08 | $13.10M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $2.63M 10-Q · filed 2024-08-09 | $4.55M 10-Q · filed 2024-08-09 | $7.18M derived: sum of 3 quarters · filed 2024-08-09 | $10.89M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.92M 10-Q · filed 2024-05-10 | $4.55M derived: sum of 2 quarters · filed 2024-05-10 | $8.25M derived: sum of 3 quarters · filed 2024-05-10 | $10.66M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $6.34M derived: sum of 2 quarters · filed 2024-03-25 | $8.74M derived: sum of 3 quarters · filed 2024-03-25 | $12.31M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $3.70M 10-Q · filed 2023-11-09 | $6.11M derived: sum of 2 quarters · filed 2023-11-09 | $9.67M 10-Q · filed 2023-11-09 | $16.05M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $2.40M 10-Q · filed 2023-08-08 | $5.97M 10-Q · filed 2023-08-08 | $12.34M derived: sum of 3 quarters · filed 2023-08-08 | $15.38M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $3.57M 10-Q · filed 2023-05-09 | $9.94M derived: sum of 2 quarters · filed 2023-05-09 | $12.98M derived: sum of 3 quarters · filed 2023-05-09 | $15.80M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.41M derived: sum of 2 quarters · filed 2023-03-23 | $12.23M derived: sum of 3 quarters · filed 2023-03-23 | $14.24M 10-K · filed 2023-03-23 | $16.94M 10-K · filed 2022-04-15 | |||
| 2021-09-30 | $3.04M 10-Q · filed 2022-11-09 | $2.97M 10-Q · filed 2021-11-15 | $5.85M derived: sum of 2 quarters · filed 2022-11-09 | $7.86M 10-Q · filed 2022-11-09 | $8.29M 10-Q · filed 2021-11-15 | $9.05M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $2.82M 10-Q · filed 2022-08-12 | $2.75M 10-Q · filed 2021-08-12 | $4.83M 10-Q · filed 2022-08-12 | $5.33M 10-Q · filed 2021-08-12 | $6.01M derived: sum of 3 quarters · filed 2022-08-12 | $8.02M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $2.01M 10-Q · filed 2022-07-08 | $2.58M 10-Q · filed 2021-05-12 | $3.19M derived: sum of 2 quarters · filed 2022-07-08 | $5.20M derived: sum of 3 quarters · filed 2022-07-08 | $6.92M derived: sum of 4 quarters · filed 2022-07-08 | |||
| 2020-12-31 | $1.18M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $3.19M derived: sum of 2 quarters · filed 2022-07-07 | $4.91M derived: sum of 3 quarters · filed 2022-07-07 | $6.88M 10-K/A · filed 2022-07-07 | $8.22M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $2.01M 10-Q · filed 2021-11-15 | $3.73M derived: sum of 2 quarters · filed 2021-11-15 | $5.70M 10-Q · filed 2021-11-15 | $8.32M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $1.72M 10-Q · filed 2021-08-12 | $3.69M 10-Q · filed 2021-08-12 | $6.31M derived: sum of 3 quarters · filed 2021-08-12 | $9.76M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.97M 10-Q · filed 2021-05-12 | $4.59M derived: sum of 2 quarters · filed 2021-05-12 | $8.04M derived: sum of 3 quarters · filed 2021-05-12 | $9.91M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $6.07M derived: sum of 2 quarters · filed 2021-03-25 | $7.94M derived: sum of 3 quarters · filed 2021-03-25 | $9.80M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $3.45M 10-Q · filed 2020-11-09 | $5.32M derived: sum of 2 quarters · filed 2020-11-09 | $7.18M 10-Q · filed 2020-11-09 | $9.67M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.87M 10-Q · filed 2020-08-06 | $3.73M 10-Q · filed 2020-08-06 | $6.22M derived: sum of 3 quarters · filed 2020-08-06 | $9.71M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.86M 10-Q · filed 2020-05-06 | $4.35M derived: sum of 2 quarters · filed 2020-05-06 | $7.84M derived: sum of 3 quarters · filed 2020-05-06 | $10.88M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $5.98M derived: sum of 2 quarters · filed 2020-03-04 | $9.02M derived: sum of 3 quarters · filed 2020-03-04 | $12.50M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $3.49M 10-Q · filed 2019-11-07 | $6.53M derived: sum of 2 quarters · filed 2019-11-07 | $10.01M 10-Q · filed 2019-11-07 | $14.18M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $3.04M 10-Q · filed 2019-08-08 | $6.52M 10-Q · filed 2019-08-08 | $10.69M derived: sum of 3 quarters · filed 2019-08-08 | $14.90M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $3.48M 10-Q · filed 2019-05-08 | $7.65M derived: sum of 2 quarters · filed 2019-05-08 | $11.86M derived: sum of 3 quarters · filed 2019-05-08 | $15.34M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.39M derived: sum of 2 quarters · filed 2019-03-01 | $11.86M derived: sum of 3 quarters · filed 2019-03-01 | $14.97M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $4.21M 10-Q · filed 2018-11-13 | $7.69M derived: sum of 2 quarters · filed 2018-11-13 | $10.79M 10-Q · filed 2018-11-13 | $14.66M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $3.48M 10-Q · filed 2018-08-03 | $6.58M 10-Q · filed 2018-08-03 | $10.44M derived: sum of 3 quarters · filed 2018-08-03 | $14.09M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $3.10M 10-Q · filed 2018-05-11 | $6.97M derived: sum of 2 quarters · filed 2018-05-11 | $10.62M derived: sum of 3 quarters · filed 2018-05-11 | $14.68M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $7.51M derived: sum of 2 quarters · filed 2018-03-02 | $11.57M derived: sum of 3 quarters · filed 2018-03-02 | $14.02M 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | $3.65M 10-Q · filed 2017-11-14 | $7.71M derived: sum of 2 quarters · filed 2017-11-14 | $10.15M 10-Q · filed 2017-11-14 | $12.83M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $4.06M 10-Q · filed 2017-08-04 | $6.50M 10-Q · filed 2017-08-04 | $9.18M derived: sum of 3 quarters · filed 2017-08-04 | $10.53M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $2.44M 10-Q · filed 2017-05-05 | $5.12M derived: sum of 2 quarters · filed 2017-05-05 | $6.47M derived: sum of 3 quarters · filed 2017-05-05 | $8.02M derived: sum of 4 quarters · filed 2017-05-05 | ||||
| 2015-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.03M derived: sum of 2 quarters · filed 2017-02-23 | $5.57M derived: sum of 3 quarters · filed 2017-02-23 | $6.68M 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | $1.35M 10-Q · filed 2016-11-01 | $2.90M derived: sum of 2 quarters · filed 2016-11-01 | $4.00M 10-Q · filed 2016-11-01 | $4.39M derived: sum of 4 quarters · filed 2016-11-01 | ||||
| 2015-06-30 | $1.54M 10-Q · filed 2016-08-10 | $2.65M 10-Q · filed 2016-08-10 | $3.04M derived: sum of 3 quarters · filed 2016-08-10 | $3.63M derived: sum of 4 quarters · filed 2016-08-10 | ||||
| 2015-03-31 | $1.10M 10-Q · filed 2016-05-13 | $1.50M derived: sum of 2 quarters · filed 2016-05-13 | $2.09M derived: sum of 3 quarters · filed 2016-05-13 | $2.69M derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | $393.27K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $985.32K derived: sum of 2 quarters · filed 2016-03-30 | $1.59M derived: sum of 3 quarters · filed 2016-03-30 | $2.46M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $592.05K 10-Q · filed 2015-11-12 | $1.19M derived: sum of 2 quarters · filed 2015-11-12 | $2.07M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $602.68K 10-Q · filed 2015-08-12 | $1.48M 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | $874.08K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |